Page 43 - Early Access Program News Today

Joint publication with Hospices Civils de Lyon in 'Frontiers in Medicine' Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy

Elon Musk Hypes Up Tesla Full Self-Driving Beta Update: Release Date, Pure Vision, and More Mind-Blowing Features Tesla is releasing a new feature on its improved Full Self-Driving Technology, with CEO Elon Musk confirming the said development on Twitter. Photo : Justin Sullivan/Getty Images Tesla is releasing a new feature on its improved Full Self-Driving Technology, with CEO Elon Musk confirming the said development on Twitter. Tesla is an electric vehicle manufacturer built with the conce...

ShortDot, a domain name registry company, has announced the launch of .cfd ( #ClothingFashionDesign), a specialized generic top-level domain (gTLD) for clothing brands, fashion designers, retailers, influencers, bloggers, consumers and lifestyle ecommerce stores. TLDs were developed in the 1980s and have unique purposes ( e.g., .com, commercial; .org, nonprofit organizations; .net, network and internet-related organizations; .edu, educational; .gov, government entities). ShortDots webpage for ...

email article When Neil Shneider, MD, PhD, got results back that Lisa Stockman Mauriellos amyotrophic lateral sclerosis (ALS) was driven by a SOD1 mutation, enrollment in the VALOR study had just closed. The phase III trial is testing Biogens investigational antisense oligonucleotide (ASO) aimed at knocking down levels of the mutant protein thought to play a major role in contributing to ALS in the 2% of patients with SOD1 mutations. Shneider, an investigator on the VALOR trial at Colum...

Oncopeptides submits application for conditional marketing authorization of melflufen in the EU News provided by Share this article Share this article STOCKHOLM, April 16, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has submitted an application to the European Medicines Agency, EMA, for conditional marketing authorization of m...

Pherecydes Pharma Announces Its 2020 Annual Financial Results and Confirms Its 2021 Outlook Regulatory News: Pherecydes Pharma (FR0011651694 - ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces its annual results for the year to December 31, 2020 and confirms its development prospects for 2021. Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecyd...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

A Preclinical Trial Demonstrates the Benefits of Inhaled Pherecydes Pharma Phages in Treating Ventilation-Associated Pneumonia th Annual Inhalation and Respiratory Drug Delivery Congress (April 20-21, 2021) Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that Nathalie Heuzé-Vourch of the Centre dEtude des Pathologies Respiratoires (...

Message : Required fields TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain preliminary financial results for the first quarter ended March 31, 2021. As discussed during HTG’s earnings conference call on March 25, the company believes its full year 2021 revenue could grow 30% to 40% over 2020 levels as it navigates a resurgence of COVID-19, whic...

Bakkt launches payments app as institutions compete for crypto assets Bakkt believes its new crypto payments app will unlock more than $1 trillion worth of digital assets for commerce. 5563 Total views News Major financial institutions are expanding their cryptocurrency services, with Bakkt launching its digital asset payments application for the general public. Bakkt was launched by Intercontinental Exchange in 2018, with the firm offering Bitcoin futures contracts to accredited inve...